Khiron Life Sciences Corp.

KHRN.H

CA49374L3065

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 08:24:46 05/05/2023 pm IST			5-day change	1st Jan Change
0.04 ^CAD	-.--%		-.--%	-.--%

2023	Colombia's cannabis industry in crisis over regulatory, political hurdles	RE
2023	2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	CI

Khiron Life Sciences Corp. Provides Sales Guidance for the First Quarter of 2022

May 02, 2022 at 04:45 pm IST

Khiron Life Sciences Corp. provided sales guidance for the first quarter of 2022. The Corporation forecasts first quarter 2022 sales revenue of $4.5 million for the quarter.

Latest news about Khiron Life Sciences Corp.

Colombia's cannabis industry in crisis over regulatory, political hurdles	21/12	RE
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	17/11	CI
2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. for CAD 3 million.	28/23/28	CI
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization	21/23/21	CI
Khiron Life Sciences Brief: On Filing of Audited Annual Financial Statements, Co Says Won't Make It On Or Before the Prescribed Deadline of May 1, 2023, as a Result of the Change in CFO	18/23/18	MT
Khiron Life Sciences Brief: Appointing Michael O'Connor as Chief Financial Officer, Replacing Ms. Helen Bellwood	18/23/18	MT
Khiron Life Sciences Announces CFO Changes	18/23/18	CI
Toronto Stocks Climb; TerrAscend Rises on Plans to Apply for TSX Listing	14/23/14	DJ
Khiron Life Sciences Plans Overnight Marketed Offering of Share Units	14/23/14	MT
Khiron Life Sciences Secures Additional Loan with Investment-Grade Bank	17/23/17	MT
Khiron Life Sciences Corp. Announces That Its Wholly Owned Subsidiary Zerenia Colombia Closes an Unsecured Revolving Credit Facility of CAD 580,000 with Private Financing Company in Colombia	14/23/14	CI
Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia	19/23/19	MT
Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient	16/23/16	MT
Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated to Cannabis-Based Medication and Clinic Fees for A Patient Enrolled in Zerenia Clinics UK	16/23/16	CI
Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Company	09/23/09	CI
Khiron Up 41% As Notes Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products	05/23/05	MT
Transcript : Khiron Life Sciences Corp., Q3 2022 Earnings Call, Nov 30, 2022	30/22/30
Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Khiron Begins Sales in Switzerland, Increases Offerings in Germany, UK	16/22/16	MT
Khiron Life Sciences Corp. Begins Sales in Switzerland and Expands Its Medical Cannabis Portfolio in Germany and the United Kingdom	16/22/16	CI
Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference	13/22/13	MT
Khiron Life Sciences Corp.'s Equity Buyback announced on September 9, 2021 has expired.	13/22/13	CI
Khiron Life Sciences Up 4% after Reporting Launch of New Cannabis Products in Europe	01/22/01	MT
Khiron Launches New Cannabis Products in Europe Including Stellar Genetics from California	01/22/01	CI
Transcript : Khiron Life Sciences Corp., Q2 2022 Earnings Call, Aug 29, 2022	29/22/29

Chart Khiron Life Sciences Corp.

Duration

Period

More charts

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
KHIRON LIFE SCIENCES CORP.	-.--%	6.8M
DONG-E-E-JIAO CO.,LTD.	+39.27%	6.07B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.60%	4.42B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.27%	3.26B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	3B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.88%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+43.78%	1.89B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-11.89%	1.63B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.67%	1.6B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.39%	1.54B

Alternative Medicine